Feature Channels:

Autoimmune Diseases

Add to Favorites Subscribe Share
fbshare-Autoimmune Diseases

Showing results

110 of 877
Newswise: Cedars-Sinai Receives $20M to Create Kao Autoimmunity Institute

Cedars-Sinai Receives $20M to Create Kao Autoimmunity Institute

Cedars-Sinai

Cedars-Sinai today announced a $20 million gift from Dr. and Mrs. Min H. Kao and the Kao Family Foundation to create the Kao Autoimmunity Institute to advance research and treatment of rheumatologic diseases. The gift also will establish the Scleroderma Program within the institute to provide interdisciplinary and integrated care for scleroderma patients and to support research, outreach, training and education to help those with the disease.

Channels: Arthritis, Autoimmune Diseases, Bone Health, Immunology,

Released:
10-Dec-2019 9:00 AM EST
Research Results
Newswise: Taming chronic inflammation may reduce illness, save lives
  • Embargo expired:
    5-Dec-2019 11:00 AM EST
Released:
5-Dec-2019 5:00 AM EST
Announcement

Simulating amino acid starvation may improve dengue vaccines

Cornell University

In a new paper in Science Signaling, researchers at the University of Hyderabad in India and the Cornell University College of Veterinary Medicine show that a plant-based compound called halofuginone improves the immune response to a potential vaccine against dengue virus.

Channels: All Journal News, Autoimmune Diseases, Immunology, Infectious Diseases, Plants, Vaccines,

Released:
26-Nov-2019 4:05 PM EST
Research Results
image001.png
  • Embargo expired:
    13-Nov-2019 2:00 PM EST

Slowing the Progression of Multiple Sclerosis

Universite de Montreal

By identifying a molecule that delays the progression of MS, researchers pave the way for new therapies for the nearly 77,000 Canadians living with the disease.

Channels: All Journal News, Autoimmune Diseases, Neuro, Pharmaceuticals, Local - Canada, Grant Funded News,

Released:
12-Nov-2019 4:30 PM EST
Research Results
ACR-Logo-2019 .jpg
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

Limited Availability of Lupus Laboratory Tests, Such As ANA, in Developing Nations Affects Global Usefulness of Criteria and Clinical Trials

American College of Rheumatology (ACR)

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, supportive laboratory assays to diagnose lupus, specifically the antinuclear antibody (ANA) test, are less often offered in developing nations due to a relative lack of resources.

Channels: Autoimmune Diseases, Clinical Trials, Lupus, Medical Meetings,

Released:
6-Nov-2019 12:00 PM EST
Research Results
ACR-Logo-2019 .jpg
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

Half of People with RA Treated with Immune Checkpoint Inhibitors for Cancer Experience Flare, but Most Able to Continue Treatment

American College of Rheumatology (ACR)

A new study found that cancer patients with a pre-existing autoimmune disease receiving immune checkpoint inhibitors as treatment are likely to experience a flare.

Channels: Arthritis, Autoimmune Diseases, Cancer, Immunology, Medical Meetings,

Released:
6-Nov-2019 12:00 PM EST
Research Results
ACR-Logo-2019 .jpg
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

Live Zoster Vaccine Safe and Effective for People Taking TNF Inhibitors

American College of Rheumatology (ACR)

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, the live zoster virus vaccine is safe for people who are currently receiving tumor necrosis factor inhibitor (TNFi) biologic therapies for various indications.

Channels: Arthritis, Autoimmune Diseases, Bone Health, Vaccines, Medical Meetings,

Released:
6-Nov-2019 12:00 PM EST
Research Results
ACR-Logo-2019 .jpg
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

Physicians Should Consider Hydroxychloroquine to Reduce the Risk of Recurrent Congenital Heart Block in Subsequent Pregnancies of Women with Anti-SSA/Ro Antibodies

American College of Rheumatology (ACR)

New research findings presented at the 2019 ACR/ARP Annual Meeting discovered that hydroxychloroquine (HCQ) significantly reduces the recurrence rate of congenital heart block in subsequent pregnancies of women with anti-SSA/ Ro antibodies, regardless of their health status.

Channels: Autoimmune Diseases, Cardiovascular Health, Immunology, Liver Disease, Neuro, Children's Health, Medical Meetings,

Released:
6-Nov-2019 12:00 PM EST
Research Results
Newswise: Ultrasound to Guide Treatment Strategy Not Beneficial in Early RA
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

Ultrasound to Guide Treatment Strategy Not Beneficial in Early RA

American College of Rheumatology (ACR)

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, a treatment strategy guided by ultrasound information use does not appear to provide better treatment decisions in patients with early rheumatoid arthritis.

Channels: Arthritis, Bone Health, All Journal News, Autoimmune Diseases, Medical Meetings,

Released:
6-Nov-2019 12:00 PM EST
Research Results

Showing results

110 of 877

Chat now!
4.65661